Targeted next-generation sequencing in steroid-resistant nephrotic syndrome

Mutations in multiple glomerular genes may influence disease severity

Gemma Bullich, Daniel Trujillano, Sheila Santín, Stephan Ossowski, Santiago Mendizábal, Gloria Fraga, Álvaro Madrid, Gema Ariceta, José Ballarín, Roser Torra, Xavier P. Estivill, Elisabet Ars

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Genetic diagnosis of steroid-resistant nephrotic syndrome (SRNS) using Sanger sequencing is complicated by the high genetic heterogeneity and phenotypic variability of this disease. We aimed to improve the genetic diagnosis of SRNS by simultaneously sequencing 26 glomerular genes using massive parallel sequencing and to study whether mutations in multiple genes increase disease severity. High-throughput mutation analysis was performed in 50 SRNS and/or focal segmental glomerulosclerosis (FSGS) patients, a validation cohort of 25 patients with known pathogenic mutations, and a discovery cohort of 25 uncharacterized patients with probable genetic etiology. In the validation cohort, we identified the 42 previously known pathogenic mutations across NPHS1, NPHS2, WT1, TRPC6, and INF2 genes. In the discovery cohort, disease-causing mutations in SRNS/FSGS genes were found in nine patients. We detected three patients with mutations in an SRNS/FSGS gene and COL4A3. Two of them were familial cases and presented a more severe phenotype than family members with mutation in only one gene. In conclusion, our results show that massive parallel sequencing is feasible and robust for genetic diagnosis of SRNS/FSGS. Our results indicate that patients carrying mutations in an SRNS/FSGS gene and also in COL4A3 gene have increased disease severity.

Original languageEnglish
Pages (from-to)1192-1199
Number of pages8
JournalEuropean Journal of Human Genetics
Volume23
Issue number9
DOIs
Publication statusPublished - 14 Sep 2015
Externally publishedYes

Fingerprint

Nephrotic Syndrome
Focal Segmental Glomerulosclerosis
Steroids
Mutation
Genes
Genetic Heterogeneity
Phenotype

ASJC Scopus subject areas

  • Genetics
  • Genetics(clinical)

Cite this

Targeted next-generation sequencing in steroid-resistant nephrotic syndrome : Mutations in multiple glomerular genes may influence disease severity. / Bullich, Gemma; Trujillano, Daniel; Santín, Sheila; Ossowski, Stephan; Mendizábal, Santiago; Fraga, Gloria; Madrid, Álvaro; Ariceta, Gema; Ballarín, José; Torra, Roser; Estivill, Xavier P.; Ars, Elisabet.

In: European Journal of Human Genetics, Vol. 23, No. 9, 14.09.2015, p. 1192-1199.

Research output: Contribution to journalArticle

Bullich, G, Trujillano, D, Santín, S, Ossowski, S, Mendizábal, S, Fraga, G, Madrid, Á, Ariceta, G, Ballarín, J, Torra, R, Estivill, XP & Ars, E 2015, 'Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: Mutations in multiple glomerular genes may influence disease severity', European Journal of Human Genetics, vol. 23, no. 9, pp. 1192-1199. https://doi.org/10.1038/ejhg.2014.252
Bullich, Gemma ; Trujillano, Daniel ; Santín, Sheila ; Ossowski, Stephan ; Mendizábal, Santiago ; Fraga, Gloria ; Madrid, Álvaro ; Ariceta, Gema ; Ballarín, José ; Torra, Roser ; Estivill, Xavier P. ; Ars, Elisabet. / Targeted next-generation sequencing in steroid-resistant nephrotic syndrome : Mutations in multiple glomerular genes may influence disease severity. In: European Journal of Human Genetics. 2015 ; Vol. 23, No. 9. pp. 1192-1199.
@article{fabde02b21df4151a3bc89f62e7e7df3,
title = "Targeted next-generation sequencing in steroid-resistant nephrotic syndrome: Mutations in multiple glomerular genes may influence disease severity",
abstract = "Genetic diagnosis of steroid-resistant nephrotic syndrome (SRNS) using Sanger sequencing is complicated by the high genetic heterogeneity and phenotypic variability of this disease. We aimed to improve the genetic diagnosis of SRNS by simultaneously sequencing 26 glomerular genes using massive parallel sequencing and to study whether mutations in multiple genes increase disease severity. High-throughput mutation analysis was performed in 50 SRNS and/or focal segmental glomerulosclerosis (FSGS) patients, a validation cohort of 25 patients with known pathogenic mutations, and a discovery cohort of 25 uncharacterized patients with probable genetic etiology. In the validation cohort, we identified the 42 previously known pathogenic mutations across NPHS1, NPHS2, WT1, TRPC6, and INF2 genes. In the discovery cohort, disease-causing mutations in SRNS/FSGS genes were found in nine patients. We detected three patients with mutations in an SRNS/FSGS gene and COL4A3. Two of them were familial cases and presented a more severe phenotype than family members with mutation in only one gene. In conclusion, our results show that massive parallel sequencing is feasible and robust for genetic diagnosis of SRNS/FSGS. Our results indicate that patients carrying mutations in an SRNS/FSGS gene and also in COL4A3 gene have increased disease severity.",
author = "Gemma Bullich and Daniel Trujillano and Sheila Sant{\'i}n and Stephan Ossowski and Santiago Mendiz{\'a}bal and Gloria Fraga and {\'A}lvaro Madrid and Gema Ariceta and Jos{\'e} Ballar{\'i}n and Roser Torra and Estivill, {Xavier P.} and Elisabet Ars",
year = "2015",
month = "9",
day = "14",
doi = "10.1038/ejhg.2014.252",
language = "English",
volume = "23",
pages = "1192--1199",
journal = "European Journal of Human Genetics",
issn = "1018-4813",
publisher = "Nature Publishing Group",
number = "9",

}

TY - JOUR

T1 - Targeted next-generation sequencing in steroid-resistant nephrotic syndrome

T2 - Mutations in multiple glomerular genes may influence disease severity

AU - Bullich, Gemma

AU - Trujillano, Daniel

AU - Santín, Sheila

AU - Ossowski, Stephan

AU - Mendizábal, Santiago

AU - Fraga, Gloria

AU - Madrid, Álvaro

AU - Ariceta, Gema

AU - Ballarín, José

AU - Torra, Roser

AU - Estivill, Xavier P.

AU - Ars, Elisabet

PY - 2015/9/14

Y1 - 2015/9/14

N2 - Genetic diagnosis of steroid-resistant nephrotic syndrome (SRNS) using Sanger sequencing is complicated by the high genetic heterogeneity and phenotypic variability of this disease. We aimed to improve the genetic diagnosis of SRNS by simultaneously sequencing 26 glomerular genes using massive parallel sequencing and to study whether mutations in multiple genes increase disease severity. High-throughput mutation analysis was performed in 50 SRNS and/or focal segmental glomerulosclerosis (FSGS) patients, a validation cohort of 25 patients with known pathogenic mutations, and a discovery cohort of 25 uncharacterized patients with probable genetic etiology. In the validation cohort, we identified the 42 previously known pathogenic mutations across NPHS1, NPHS2, WT1, TRPC6, and INF2 genes. In the discovery cohort, disease-causing mutations in SRNS/FSGS genes were found in nine patients. We detected three patients with mutations in an SRNS/FSGS gene and COL4A3. Two of them were familial cases and presented a more severe phenotype than family members with mutation in only one gene. In conclusion, our results show that massive parallel sequencing is feasible and robust for genetic diagnosis of SRNS/FSGS. Our results indicate that patients carrying mutations in an SRNS/FSGS gene and also in COL4A3 gene have increased disease severity.

AB - Genetic diagnosis of steroid-resistant nephrotic syndrome (SRNS) using Sanger sequencing is complicated by the high genetic heterogeneity and phenotypic variability of this disease. We aimed to improve the genetic diagnosis of SRNS by simultaneously sequencing 26 glomerular genes using massive parallel sequencing and to study whether mutations in multiple genes increase disease severity. High-throughput mutation analysis was performed in 50 SRNS and/or focal segmental glomerulosclerosis (FSGS) patients, a validation cohort of 25 patients with known pathogenic mutations, and a discovery cohort of 25 uncharacterized patients with probable genetic etiology. In the validation cohort, we identified the 42 previously known pathogenic mutations across NPHS1, NPHS2, WT1, TRPC6, and INF2 genes. In the discovery cohort, disease-causing mutations in SRNS/FSGS genes were found in nine patients. We detected three patients with mutations in an SRNS/FSGS gene and COL4A3. Two of them were familial cases and presented a more severe phenotype than family members with mutation in only one gene. In conclusion, our results show that massive parallel sequencing is feasible and robust for genetic diagnosis of SRNS/FSGS. Our results indicate that patients carrying mutations in an SRNS/FSGS gene and also in COL4A3 gene have increased disease severity.

UR - http://www.scopus.com/inward/record.url?scp=84939267798&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84939267798&partnerID=8YFLogxK

U2 - 10.1038/ejhg.2014.252

DO - 10.1038/ejhg.2014.252

M3 - Article

VL - 23

SP - 1192

EP - 1199

JO - European Journal of Human Genetics

JF - European Journal of Human Genetics

SN - 1018-4813

IS - 9

ER -